Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Carl Collins Insider Profile
4 Followers
Christopher Carl Collins, Director, Ten Percent Owner at Amplia Therapeutics Ltd., holds 37.89M shares in Amplia Therapeutics Ltd. (Ticker: INNMF). Most recently, Christopher Carl Collins Bought $4,000,000 shares of Amplia Therapeutics Ltd. on Sep 12, 2016 for an estimated value of 1.00M.
Christopher Carl Collins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Carl Collins's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Christopher Carl Collins holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 12, 2016 - Sep 12, 2017
Return:-93.30%
The most profitable trade made by Christopher Carl Collins
Christopher Carl Collins's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Carl Collins's performance on stock
You May Also Like
Christopher Carl Collins insider profile FAQ
What is the percentage of profitable transactions made by Christopher Carl Collins?
The percentage of profitable transactions made by Christopher Carl Collins is ―.
What is the average return per transaction made by Christopher Carl Collins?
The average return per transaction made by Christopher Carl Collins is ―.
What stocks does Christopher Carl Collins hold?
Christopher Carl Collins holds: INNMF stocks.
What was Christopher Carl Collins’s latest transaction?
Christopher Carl Collins latest transaction was an Informative Buy of $1.00M.
What was Christopher Carl Collins's most profitable transaction?
Christopher Carl Collins’s most profitable transaction was an Informative Buy of INNMF stock on September 12, 2016. The return on the trade was -93.30%.
What is Christopher Carl Collins's role in Amplia Therapeutics Ltd.?
Christopher Carl Collins's role in Amplia Therapeutics Ltd. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.